Drugs List

Drugs A-Z List - V
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Drugs List [Browse by brand or generic name]
Valchlor (mechlorethamine) Gel - FDA

Description : VALCHLOR is a topical product that contains mechlorethamine HCl, an alkylating drug. Mechloreth...

  • Indications
  • VALCHLOR is an alkylating drug indicated for the topical treatment of Stage IA and IB mycosis fungoides-type cutaneous T-cell lymphoma in patients who have received prior
  •   Read More
Valchlor (mechlorethamine) Gel - FDA

Description : VALCHLOR is a topical product that contains mechlorethamine HCl, an alkylating drug. Mechlo...

  • Indications
  • VALCHLOR is an alkylating drug indicated for the topical treatment of Stage IA and IB mycosis fungoides-type cutaneous T-cell lymphoma in patients who have received prior
  •   Read More
Valcyte valganciclovir (Pronunciation: val gan SYE kloe ve - FDA

Description : VALCYTE contains valganciclovir hydrochloride (valganciclovir HCl), a hydrochloride salt of...

  • Indications
  • Adult Patients Treatment of Cytomegalovirus (CMV) Retinitis VALCYTE is indicated for the treatment of CMV retinitis in patients with acquired immunodeficiency syndrome (
  •   Read More
Valcyte valganciclovir (Pronunciation: val gan SYE kloe ve - Multum

Description : VALCYTE contains valganciclovir hydrochloride (valganciclovir HCl), a hydrochloride salt of...

  • Indications
  • Adult Patients Treatment of Cytomegalovirus (CMV) Retinitis VALCYTE is indicated for the treatment of CMV retinitis in patients with acquired immunodeficiency syndrome (
  •   Read More
Valcyte valganciclovir (Pronunciation: val gan SYE kloe ve - FDA

Description : VALCYTE contains valganciclovir hydrochloride (valganciclovir HCl), a hydrochloride salt of...

  • Indications
  • Adult Patients Treatment of Cytomegalovirus (CMV) Retinitis VALCYTE is indicated for the treatment of CMV retinitis in patients with acquired immunodeficiency syndrome (
  •   Read More
Valcyte valganciclovir (Pronunciation: val gan SYE kloe ve - Multum

Description : VALCYTE contains valganciclovir hydrochloride (valganciclovir HCl), a hydrochloride salt of...

  • Indications
  • Adult Patients Treatment of Cytomegalovirus (CMV) Retinitis VALCYTE is indicated for the treatment of CMV retinitis in patients with acquired immunodeficiency syndrome (
  •   Read More
Valium  diazepam (Pronunciation: dye AZ e pam - FDA

Description : Valium (diazepam) is a benzodiazepine derivative. The chemical name of diazepam is 7-chloro...

  • Indications
  • Valium is indicated for the management of anxiety disorders or for the short-term relief of the symptoms of anxiety. Anxiety or tension associated with the stress of ever
  •   Read More
Valium diazepam (Pronunciation: dye AZ e pam) - Multum

Description : Valium (diazepam) is a benzodiazepine derivative. The chemical name of diazepam is 7-chloro...

  • Indications
  • Valium is indicated for the management of anxiety disorders or for the short-term relief of the symptoms of anxiety. Anxiety or tension associated with the stress of ever
  •   Read More
Valium diazepam (Pronunciation: dye AZ e pam) - FDA

Description : Valium (diazepam) is a benzodiazepine derivative. The chemical name of diazepam is 7-chloro...

  • Indications
  • Valium is indicated for the management of anxiety disorders or for the short-term relief of the symptoms of anxiety. Anxiety or tension associated with the stress of ever
  •   Read More
Valium diazepam (Pronunciation: dye AZ e pam) - Multum

Description : Valium (diazepam) is a benzodiazepine derivative. The chemical name of diazepam is 7-chloro...

  • Indications
  • Valium is indicated for the management of anxiety disorders or for the short-term relief of the symptoms of anxiety. Anxiety or tension associated with the stress of ever
  •   Read More
Valstar valrubicin (Pronunciation: val ROO bi sin) - FDA

Description : Valrubicin (N-trifluoroacetyladriamycin-14-valerate), a semisynthetic analog of the anthra-...

  • Indications
  • VALSTAR (valrubicin) is indicated for intravesical therapy of BCG-refractory carcinoma in situ (CIS) of the urinary bladder in patients for whom immediate cystectomy would
  •   Read More
Valstar valrubicin (Pronunciation: val ROO bi sin) - Multum

Description : Valrubicin (N-trifluoroacetyladriamycin-14-valerate), a semisynthetic analog of the anthra-...

  • Indications
  • VALSTAR (valrubicin) is indicated for intravesical therapy of BCG-refractory carcinoma in situ (CIS) of the urinary bladder in patients for whom immediate cystectomy would
  •   Read More
Valstar valrubicin (Pronunciation: val ROO bi sin) - FDA

Description : Valrubicin (N-trifluoroacetyladriamycin-14-valerate), a semisynthetic analog of the anthra-...

  • Indications
  • VALSTAR (valrubicin) is indicated for intravesical therapy of BCG-refractory carcinoma in situ (CIS) of the urinary bladder in patients for whom immediate cystectomy would be
  •   Read More
Valstar valrubicin (Pronunciation: val ROO bi sin) - Multum

Description : Valrubicin (N-trifluoroacetyladriamycin-14-valerate), a semisynthetic analog of the anthra-...

  • Indications
  • VALSTAR (valrubicin) is indicated for intravesical therapy of BCG-refractory carcinoma in situ (CIS) of the urinary bladder in patients for whom immediate cystectomy would
  •   Read More
Valtrex valacyclovir (Pronunciation: val a SYE kloe veer) - FDA

Description : VALTREX (valacyclovir hydrochloride) is the hydrochloride salt of the L-valyl ester of the ...

  • Indications
  • Adult Patients Cold Sores (Herpes Labialis) VALTREX® (valacyclovir hydrochloride) Caplets are indicated for treatment of cold sores (herpes labialis). The efficacy o
  •   Read More
Valtrex valacyclovir (Pronunciation: val a SYE kloe veer) - Multum

Description : VALTREX (valacyclovir hydrochloride) is the hydrochloride salt of the L-valyl ester of the ...

  • Indications
  • Adult Patients Cold Sores (Herpes Labialis) VALTREX® (valacyclovir hydrochloride) Caplets are indicated for treatment of cold sores (herpes labialis). The efficacy o
  •   Read More
Valtrex valacyclovir (Pronunciation: val a SYE kloe veer) - FDA

Description : VALTREX (valacyclovir hydrochloride) is the hydrochloride salt of the L-valyl ester of the ...

  • Indications
  • Adult Patients Cold Sores (Herpes Labialis) VALTREX® (valacyclovir hydrochloride) Caplets are indicated for treatment of cold sores (herpes labialis). The efficacy o
  •   Read More
Valtrex valacyclovir (Pronunciation: val a SYE kloe veer) - Multum

Description : VALTREX (valacyclovir hydrochloride) is the hydrochloride salt of the L-valyl ester of the ...

  • Indications
  • Adult Patients Cold Sores (Herpes Labialis) VALTREX® (valacyclovir hydrochloride) Caplets are indicated for treatment of cold sores (herpes labialis). The efficacy o
  •   Read More
Valtropin (somatropin rDNA origin for injection, USP) - FDA

Description : Valtropin (somatropin injection) ® [somatropin (rDNA origin) for injection] is a polype...

  • Indications
  • Pediatric Patients: Valtropin (somatropin injection) ® is indicated for the treatment of pediatric patients who have growth failure due to inadequate secretion of end
  •   Read More
Valtropin (somatropin rDNA origin for injection, USP) - FDA

Description : Valtropin (somatropin injection) ® [somatropin (rDNA origin) for injection] is a polypeptid...

  • Indications
  • Pediatric Patients: Valtropin (somatropin injection) ® is indicated for the treatment of pediatric patients who have growth failure due to inadequate secretion of end
  •   Read More
Valturna aliskiren and valsartan (Pronunciation: a LIS ke r - FDA

Description : Valturna is a single tablet for oral administration of aliskiren (an orally active, nonpept...

  • Indications
  • Valturna is indicated for the treatment of hypertension, to lower blood pressure. Lowering blood pressure reduces the risk of fatal and nonfatal cardiovascular events, pri
  •   Read More
Valturna aliskiren and valsartan (Pronunciation: a LIS ke r - Multum

Description : Valturna is a single tablet for oral administration of aliskiren (an orally active, nonpept...

  • Indications
  • Valturna is indicated for the treatment of hypertension, to lower blood pressure. Lowering blood pressure reduces the risk of fatal and nonfatal cardiovascular events, pri
  •   Read More
Valturna aliskiren and valsartan (Pronunciation: a LIS ke r - FDA

Description : Valturna is a single tablet for oral administration of aliskiren (an orally active, nonpept...

  • Indications
  • Valturna is indicated for the treatment of hypertension, to lower blood pressure. Lowering blood pressure reduces the risk of fatal and nonfatal cardiovascular events, pri
  •   Read More
Valturna aliskiren and valsartan (Pronunciation: a LIS ke r - Multum

Description : Valturna is a single tablet for oral administration of aliskiren (an orally active, nonpept...

  • Indications
  • Valturna is indicated for the treatment of hypertension, to lower blood pressure. Lowering blood pressure reduces the risk of fatal and nonfatal cardiovascular events, pri
  •   Read More
Vancomycin Hydrochloride Vancomycin Injection, USP in GALAXY Plastic Contai - FDA

Description : Vancomycin Injection, USP in the GALAXY plastic container (PL 2040) contains vancomycin, ad...

  • Indications
  • Vancomycin is indicated for the treatment of serious or severe infections caused by susceptible strains of methicillin-resistant (beta-lactam-resistant) staphylococci. It
  •   Read More
Vancomycin Hydrochloride Vancomycin Injection, USP in GALAXY Plastic Contai - FDA

Description : Vancomycin Injection, USP in the GALAXY plastic container (PL 2040) contains vancomycin, ad...

  • Indications
  • Vancomycin is indicated for the treatment of serious or severe infections caused by susceptible strains of methicillin-resistant (beta-lactam-resistant) staphylococci. It
  •   Read More
Vaniqa eflornithine topical (Pronunciation: ee FLOOR nih - FDA

Description : VANIQA (eflornithine) is a cream containing 13.9% (139 mg/g) of anhydrous eflornithine hydr...

  • Indications
  • VANIQA (eflornithine hydrochloride) Cream, 13.9% is indicated for the reduction of unwanted facial hair in women. VANIQA (eflornithine) has only been studied on the face
  •   Read More
Vaniqa eflornithine topical (Pronunciation: ee FLOOR nih - Multum

Description : VANIQA (eflornithine) is a cream containing 13.9% (139 mg/g) of anhydrous eflornithine hydr...

  • Indications
  • VANIQA (eflornithine hydrochloride) Cream, 13.9% is indicated for the reduction of unwanted facial hair in women. VANIQA (eflornithine) has only been studied on the face
  •   Read More
Vaniqa eflornithine topical (Pronunciation: ee FLOOR nih - FDA

Description : VANIQA (eflornithine) is a cream containing 13.9% (139 mg/g) of anhydrous eflornithine hydr...

  • Indications
  • VANIQA (eflornithine hydrochloride) Cream, 13.9% is indicated for the reduction of unwanted facial hair in women. VANIQA (eflornithine) has only been studied on the face
  •   Read More
Vaniqa eflornithine topical (Pronunciation: ee FLOOR nih - Multum

Description : VANIQA (eflornithine) is a cream containing 13.9% (139 mg/g) of anhydrous eflornithine hydr...

  • Indications
  • VANIQA (eflornithine hydrochloride) Cream, 13.9% is indicated for the reduction of unwanted facial hair in women. VANIQA (eflornithine) has only been studied on the face
  •   Read More
Vantin cefpodoxime (Pronunciation: SEF poe DOX eem) - FDA

Description : Cefpodoxime proxetil is an orally administered, extended spectrum, semi-synthetic antibioti...

  • Indications
  • Cefpodoxime proxetil is indicated for the treatment of patients with mild to moderate infections caused by susceptible strains of the designated microorganisms in the cond
  •   Read More
Vantin cefpodoxime (Pronunciation: SEF poe DOX eem) - Multum

Description : Cefpodoxime proxetil is an orally administered, extended spectrum, semi-synthetic antibioti...

  • Indications
  • Cefpodoxime proxetil is indicated for the treatment of patients with mild to moderate infections caused by susceptible strains of the designated microorganisms in the cond
  •   Read More
Vantin cefpodoxime (Pronunciation: SEF poe DOX eem) - FDA

Description : Cefpodoxime proxetil is an orally administered, extended spectrum, semi-synthetic antibioti...

  • Indications
  • Cefpodoxime proxetil is indicated for the treatment of patients with mild to moderate infections caused by susceptible strains of the designated microorganisms in the cond
  •   Read More
Vantin cefpodoxime (Pronunciation: SEF poe DOX eem) - Multum

Description : Cefpodoxime proxetil is an orally administered, extended spectrum, semi-synthetic antibioti...

  • Indications
  • Cefpodoxime proxetil is indicated for the treatment of patients with mild to moderate infections caused by susceptible strains of the designated microorganisms in the cond
  •   Read More
Vaprisol conivaptan (Pronunciation: koe NYE vap tan) - FDA

Description : Conivaptan hydrochloride is chemically [1,1'-biphenyl]-2-carboxamide, N-[4-[(4,5-dihydro-2m...

  • Indications
  • VAPRISOL® is indicated to raise serum sodium in hospitalized patients with euvolemic and hypervolemic hyponatremia. Important Limitations VAPRISOL has not been shown
  •   Read More
Vaprisol conivaptan (Pronunciation: koe NYE vap tan) - Multum

Description : Conivaptan hydrochloride is chemically [1,1'-biphenyl]-2-carboxamide, N-[4-[(4,5-dihydro-2m...

  • Indications
  • VAPRISOL® is indicated to raise serum sodium in hospitalized patients with euvolemic and hypervolemic hyponatremia. Important Limitations VAPRISOL has not been shown
  •   Read More
Vaprisol conivaptan (Pronunciation: koe NYE vap tan) - FDA

Description : Conivaptan hydrochloride is chemically [1,1'-biphenyl]-2-carboxamide, N-[4-[(4,5-dihydro-2m...

  • Indications
  • VAPRISOL® is indicated to raise serum sodium in hospitalized patients with euvolemic and hypervolemic hyponatremia. Important Limitations VAPRISOL has not been shown
  •   Read More
Vaprisol conivaptan (Pronunciation: koe NYE vap tan) - Multum

Description : Conivaptan hydrochloride is chemically [1,1'-biphenyl]-2-carboxamide, N-[4-[(4,5-dihydro-2m...

  • Indications
  • VAPRISOL® is indicated to raise serum sodium in hospitalized patients with euvolemic and hypervolemic hyponatremia. Important Limitations VAPRISOL has not been shown
  •   Read More
Varithena (polidocanol) Injectable Foam - FDA

Description : Varithena™ injectable foam contains the sclerosant, polidocanol. It is intended for i...

  • Indications
  • Varithena™ (polidocanol injectable foam) is indicated for the treatment of incompetent great saphenous veins, accessory saphenous veins, and visible varicosities of the
  •   Read More
Varithena  (polidocanol) Injectable Foam - FDA

Description : Varithena™ injectable foam contains the sclerosant, polidocanol. It is intended for i...

  • Indications
  • Varithena™ (polidocanol injectable foam) is indicated for the treatment of incompetent great saphenous veins, accessory saphenous veins, and visible varicosities of the
  •   Read More
Varivax varicella virus (chickenpox) vaccine (Pronunciatio - FDA

Description : VARIVAX* [Varicella Virus Vaccine Live (Oka/Merck)] is a preparation of the Oka/Merck strai...

  • Indications
  • VARIVAX (varicella virus vaccine live) is indicated for vaccination against varicella in individuals 12 months of age and older. The duration of protection of VARIVAX (va
  •   Read More
Varivax varicella virus (chickenpox) vaccine (Pronunciatio - Multum

Description : VARIVAX* [Varicella Virus Vaccine Live (Oka/Merck)] is a preparation of the Oka/Merck strai...

  • Indications
  • VARIVAX (varicella virus vaccine live) is indicated for vaccination against varicella in individuals 12 months of age and older. The duration of protection of VARIVAX (va
  •   Read More
Varivax varicella virus (chickenpox) vaccine (Pronunciatio - FDA

Description : VARIVAX* [Varicella Virus Vaccine Live (Oka/Merck)] is a preparation of the Oka/Merck strai...

  • Indications
  • VARIVAX (varicella virus vaccine live) is indicated for vaccination against varicella in individuals 12 months of age and older. The duration of protection of VARIVAX (va
  •   Read More
Varivax varicella virus (chickenpox) vaccine (Pronunciatio - Multum

Description : VARIVAX* [Varicella Virus Vaccine Live (Oka/Merck)] is a preparation of the Oka/Merck strai...

  • Indications
  • VARIVAX (varicella virus vaccine live) is indicated for vaccination against varicella in individuals 12 months of age and older. The duration of protection of VARIVAX (va
  •   Read More
VariZIG [Varicella Zoster Immune Globulin (Human)] for Inj - FDA

Description : VARIZIG [Varicella Zoster Immune Globulin (Human)] is a solvent/detergent-treated sterile l...

  • Indications
  • VARIZIG® [Varicella Zoster Immune Globulin (Human)] is indicated for post-exposure prophylaxis of varicella in high risk individuals. High risk groups include: immu
  •   Read More
VARIZIG  [Varicella Zoster Immune Globulin (Human)] for Inj - FDA

Description : VARIZIG [Varicella Zoster Immune Globulin (Human)] is a solvent/detergent-treated sterile l...

  • Indications
  • VARIZIG® [Varicella Zoster Immune Globulin (Human)] is indicated for post-exposure prophylaxis of varicella in high risk individuals. High risk groups include: immu
  •   Read More
Vascepa  icosapent (Pronunciation: eye KOE sa pent) - FDA

Description : VASCEPA, a lipid-regulating agent, is supplied as a 1-gram amber-colored, liquid-filled sof...

  • Indications
  • VASCEPA® (icosapent ethyl) is indicated as an adjunct to diet to reduce triglyceride (TG) levels in adult patients with severe ( ≥ 500 mg/dL) hypertriglyceridemia.
  •   Read More
Vascepa icosapent (Pronunciation: eye KOE sa pent) - Multum

Description : VASCEPA, a lipid-regulating agent, is supplied as a 1-gram amber-colored, liquid-filled sof...

  • Indications
  • VASCEPA® (icosapent ethyl) is indicated as an adjunct to diet to reduce triglyceride (TG) levels in adult patients with severe ( ≥ 500 mg/dL) hypertriglyceridemia.
  •   Read More
Vascepa icosapent (Pronunciation: eye KOE sa pent) - FDA

Description : VASCEPA, a lipid-regulating agent, is supplied as a 1-gram amber-colored, liquid-filled sof...

  • Indications
  • VASCEPA® (icosapent ethyl) is indicated as an adjunct to diet to reduce triglyceride (TG) levels in adult patients with severe ( ≥ 500 mg/dL) hypertriglyceridemia.
  •   Read More
Vascepa icosapent (Pronunciation: eye KOE sa pent) - Multum

Description : VASCEPA, a lipid-regulating agent, is supplied as a 1-gram amber-colored, liquid-filled sof...

  • Indications
  • VASCEPA® (icosapent ethyl) is indicated as an adjunct to diet to reduce triglyceride (TG) levels in adult patients with severe ( ≥ 500 mg/dL) hypertriglyceridemia.
  •   Read More
Vascor (bepridil hydrochloride) - FDA

Description : VASCOR (bepridil hydrochloride) is a calcium channel blocker that has well characterized an...

  • Indications
  • Chronic Stable Angina (Classic Effort-Associated Angina) VASCOR (bepridil hydrochloride) is indicated for the treatment of chronic stable angina (classic effort-associated an
  •   Read More
Vascor (bepridil hydrochloride) - FDA

Description : VASCOR (bepridil hydrochloride) is a calcium channel blocker that has well characterized an...

  • Indications
  • Chronic Stable Angina (Classic Effort-Associated Angina) VASCOR (bepridil hydrochloride) is indicated for the treatment of chronic stable angina (classic effort-associate
  •   Read More
Vaseretic 10-25, Vaseretic 5-12.5 hydrochlorothiazide and enalapril (Pronunciation: - FDA

Description : VASERETIC® (enalapril maleate-hydrochlorothiazide) combines an angiotensin converting enzym...

  • Indications
  • VASERETIC is indicated for the treatment of hypertension. This fixed dose combination is not indicated for initial treatment (seeDOSAGE AND ADMINISTRATION). In using VA
  •   Read More
Vaseretic 10-25, Vaseretic 5-12.5  hydrochlorothiazide and enalapril (Pronunciation: - Multum

Description : VASERETIC® (enalapril maleate-hydrochlorothiazide) combines an angiotensin converting enzym...

  • Indications
  • VASERETIC is indicated for the treatment of hypertension. This fixed dose combination is not indicated for initial treatment (seeDOSAGE AND ADMINISTRATION). In using VA
  •   Read More
Vaseretic 10-25, Vaseretic 5-12.5 hydrochlorothiazide and enalapril (Pronunciation: - FDA

Description : VASERETIC® (enalapril maleate-hydrochlorothiazide) combines an angiotensin converting e...

  • Indications
  • VASERETIC is indicated for the treatment of hypertension. This fixed dose combination is not indicated for initial treatment (see DOSAGE AND ADMINISTRATION). In using VA
  •   Read More
Vaseretic 10-25, Vaseretic 5-12.5 hydrochlorothiazide and enalapril (Pronunciation: - Multum

Description : VASERETIC® (enalapril maleate-hydrochlorothiazide) combines an angiotensin converting e...

  • Indications
  • VASERETIC is indicated for the treatment of hypertension. This fixed dose combination is not indicated for initial treatment (see DOSAGE AND ADMINISTRATION). In using VA
  •   Read More
Vasocidin  (prednisolone sodium phosphate and sulfacetamide - FDA

Description : VASOCIDIN (sulfacetamide and prednisolone) is a sterile topical ophthalmic solution combini...

  • Indications
  • VASOCIDIN (sulfacetamide and prednisolone) is indicated for corticosteroid-responsive inflammatory ocular conditions for which a corticosteroid is indicated and where sup
  •   Read More
Vasostrict (vasopressin injection) - FDA

Description : Vasopressin is a polypeptide hormone that causes contraction of vascular and other smooth m...

  • Indications
  • Vasostrict® is indicated to increase blood pressure in adults with vasodilatory shock (e.g., postcardiotomy or sepsis) who remain hypotensive despite fluids and catecholam
  •   Read More
Vasostrict (vasopressin injection) - FDA

Description : Vasopressin is a polypeptide hormone that causes contraction of vascular and other smooth m...

  • Indications
  • Vasostrict® is indicated to increase blood pressure in adults with vasodilatory shock (e.g., postcardiotomy or sepsis) who remain hypotensive despite fluids and catech
  •   Read More
Vasotec enalapril (Pronunciation: e NAL a pril) - FDA

Description : VASOTEC® (enalapril maleate) is the maleate salt of enalapril, the ethyl ester of a long-ac...

  • Indications
  • Hypertension VASOTEC is indicated for the treatment of hypertension. VASOTEC is effective alone or in combination with other antihypertensive agents, especially thiazide
  •   Read More
Vasotec enalapril (Pronunciation: e NAL a pril) - Multum

Description : VASOTEC® (enalapril maleate) is the maleate salt of enalapril, the ethyl ester of a long-ac...

  • Indications
  • Hypertension VASOTEC is indicated for the treatment of hypertension. VASOTEC is effective alone or in combination with other antihypertensive agents, especially thiazide
  •   Read More
Vasotec enalapril (Pronunciation: e NAL a pril) - FDA

Description : VASOTEC® (enalapril maleate) is the maleate salt of enalapril, the ethyl ester of a lon...

  • Indications
  • Hypertension VASOTEC is indicated for the treatment of hypertension. VASOTEC is effective alone or in combination with other antihypertensive agents, especially thiazide-
  •   Read More
Vasotec enalapril (Pronunciation: e NAL a pril) - Multum

Description : VASOTEC® (enalapril maleate) is the maleate salt of enalapril, the ethyl ester of a lon...

  • Indications
  • Hypertension VASOTEC is indicated for the treatment of hypertension. VASOTEC is effective alone or in combination with other antihypertensive agents, especially thiazide-
  •   Read More
Vazculep (phenylephrine hydrochloride) Injection - FDA

Description : Phenylephrine is an alpha-1 adrenergic receptor agonist. VAZCULEP (phenylephrine hydrochlor...

  • Indications
  • VAZCULEP (phenylephrine hydrochloride) Injection, 10 mg/mL is an alpha-1 adrenergic receptor agonist indicated for the treatment of clinically important hypotension resulting
  •   Read More
Vazculep (phenylephrine hydrochloride) Injection - FDA

Description : Phenylephrine is an alpha-1 adrenergic receptor agonist. VAZCULEP (phenylephrine hydrochlor...

  • Indications
  • VAZCULEP (phenylephrine hydrochloride) Injection, 10 mg/mL is an alpha-1 adrenergic receptor agonist indicated for the treatment of clinically important hypotension result
  •   Read More
Vectibix panitumumab (Pronunciation: pan i TUE moo mab) - FDA

Description : Vectibix (panitumumab) is a recombinant, human IgG2 kappa monoclonal antibody that binds s...

  • Indications
  • Metastatic Colorectal Cancer Vectibix is indicated for the treatment of patients with wild-type KRAS (exon 2 in codons 12 or 13) metastatic colorectal cancer (mCRC) as de
  •   Read More
Vectibix panitumumab (Pronunciation: pan i TUE moo mab - Multum

Description : Vectibix (panitumumab) is a recombinant, human IgG2 kappa monoclonal antibody that binds s...

  • Indications
  • Metastatic Colorectal Cancer Vectibix is indicated for the treatment of patients with wild-type KRAS (exon 2 in codons 12 or 13) metastatic colorectal cancer (mCRC) as de
  •   Read More
Vectibix (panitumumab) Injection - FDA

Description : Vectibix (panitumumab) is a recombinant, human IgG2 kappa monoclonal antibody that binds s...

  • Indications
  • Metastatic Colorectal Cancer Vectibix is indicated for the treatment of patients with wild-type KRAS (exon 2 in codons 12 or 13) metastatic colorectal cancer (mCRC) as de
  •   Read More
Vectibix panitumumab (Pronunciation: pan i TUE moo mab) - Multum

Description : Vectibix (panitumumab) is a recombinant, human IgG2 kappa monoclonal antibody that binds s...

  • Indications
  • Metastatic Colorectal Cancer Vectibix is indicated for the treatment of patients with wild-type KRAS (exon 2 in codons 12 or 13) metastatic colorectal cancer (mCRC) as de
  •   Read More
Vectical calcitriol (topical) (Pronunciation: kal SIT ree o - FDA

Description : VECTICAL (calcitriol) Ointment 3 mcg/g is a vitamin D analog intended for topical applicati...

  • Indications
  • Indication VECTICAL (calcitriol ointment) Ointment is indicated for the topical treatment of mild to moderate plaque psoriasis in adults 18 years and older. Limitations
  •   Read More
Vectical calcitriol (topical) (Pronunciation: kal SIT ree o - Multum

Description : VECTICAL (calcitriol) Ointment 3 mcg/g is a vitamin D analog intended for topical applicati...

  • Indications
  • Indication VECTICAL (calcitriol ointment) Ointment is indicated for the topical treatment of mild to moderate plaque psoriasis in adults 18 years and older. Limitations
  •   Read More
Vectical calcitriol (topical) (Pronunciation: kal SIT ree o - FDA

Description : VECTICAL (calcitriol) Ointment 3 mcg/g is a vitamin D analog intended for topical applicati...

  • Indications
  • Indication VECTICAL (calcitriol ointment) Ointment is indicated for the topical treatment of mild to moderate plaque psoriasis in adults 18 years and older. Limitations
  •   Read More
Vectical calcitriol (topical) (Pronunciation: kal SIT ree o - Multum

Description : VECTICAL (calcitriol) Ointment 3 mcg/g is a vitamin D analog intended for topical applicati...

  • Indications
  • Indication VECTICAL (calcitriol ointment) Ointment is indicated for the topical treatment of mild to moderate plaque psoriasis in adults 18 years and older. Limitations
  •   Read More
Velcade bortezomib (Pronunciation: bor TEZ oh mib) - FDA

Description : VELCADE® (bortezomib) for Injection is an antineoplastic agent available for intraveno...

  • Indications
  • Multiple Myeloma VELCADE® (bortezomib) is indicated for the treatment of patients with multiple myeloma. Mantle Cell Lymphoma VELCADE is indicated for the treatment
  •   Read More
Velcade bortezomib (Pronunciation: bor TEZ oh mib) - Multum

Description : VELCADE® (bortezomib) for Injection is an antineoplastic agent available for intraveno...

  • Indications
  • Multiple Myeloma VELCADE® (bortezomib) is indicated for the treatment of patients with multiple myeloma. Mantle Cell Lymphoma VELCADE is indicated for the treatment
  •   Read More
Velcade bortezomib (Pronunciation: bor TEZ oh mib) - FDA

Description : VELCADE® (bortezomib) for Injection is an antineoplastic agent available for intraveno...

  • Indications
  • Multiple Myeloma VELCADE® (bortezomib) is indicated for the treatment of patients with multiple myeloma. Mantle Cell Lymphoma VELCADE is indicated for the treatment
  •   Read More
Velcade bortezomib (Pronunciation: bor TEZ oh mib) - Multum

Description : VELCADE® (bortezomib) for Injection is an antineoplastic agent available for intraveno...

  • Indications
  • Multiple Myeloma VELCADE® (bortezomib) is indicated for the treatment of patients with multiple myeloma. Mantle Cell Lymphoma VELCADE is indicated for the treatment
  •   Read More
Veletri (epoprostenol) Powder for Intravenous (IV) Adminis - FDA

Description : Epoprostenol sodium is the sodium salt of epoprostenol, formulated as a sterile lyophilized...

  • Indications
  • VELETRI is indicated for the treatment of pulmonary arterial hypertension (PAH) (WHO Group 1) to improve exercise capacity. Studies establishing effectiveness included pre
  •   Read More
Velosulin insulin human - FDA

Description : Velosulin (insulin human) ® BR is a clear solution of insulin in a phosphate buffer. Th...

Velosulin Velosulin (insulin human) ® - FDA

Description : Velosulin (insulin human) ® BR is a clear solution of insulin in a phosphate buffer. Th...

Velphoro (sucroferric oxyhydroxide) Chewable Tablets - FDA

Description : Velphoro chewable tablets are brown, circular, bi-planar, and are embossed with “PA 5...

  • Indications
  • Velphoro (sucroferric oxyhydroxide) is a phosphate binder indicated for the control of serum phosphorus levels in patients with chronic kidney disease on dialysis.
  •   Read More
Velphoro (sucroferric oxyhydroxide) Chewable Tablets - FDA

Description : Velphoro chewable tablets are brown, circular, bi-planar, and are embossed with “PA 500&r...

  • Indications
  • Velphoro (sucroferric oxyhydroxide) is a phosphate binder indicated for the control of serum phosphorus levels in patients with chronic kidney disease on dialysis.
  •   Read More
Veltin (clindamycin phosphate and tretinoin) Gel - FDA

Description : VELTIN™ (clindamycin phosphate and tretinoin) Gel, 1.2%/0.025%, is a fixed combinatio...

  • Indications
  • VELTIN™ (clindamycin phosphate and tretinoin) Gel, 1.2%/0.025% is indicated for the topical treatment of acne vulgaris in patients 12 years or older.
  •   Read More
Veltin (clindamycin phosphate and tretinoin) Gel - FDA

Description : VELTIN™ (clindamycin phosphate and tretinoin) Gel, 1.2%/0.025%, is a fixed combinatio...

  • Indications
  • VELTIN™ (clindamycin phosphate and tretinoin) Gel, 1.2%/0.025% is indicated for the topical treatment of acne vulgaris in patients 12 years or older.
  •   Read More
Venofer iron sucrose (injection) (Pronunciation: EYE urn S - FDA

Description : Venofer (iron sucrose injection, USP), an iron replacement product, is a brown, sterile, aq...

  • Indications
  • Venofer is indicated for the treatment of iron deficiency anemia in patients with chronic kidney disease (CKD).
  •   Read More
Venofer  iron sucrose (injection) (Pronunciation: EYE urn - Multum

Description : Venofer (iron sucrose injection, USP), an iron replacement product, is a brown, sterile, aq...

  • Indications
  • Venofer is indicated for the treatment of iron deficiency anemia in patients with chronic kidney disease (CKD).
  •   Read More
Venofer iron sucrose (injection) (Pronunciation: EYE urn S - FDA

Description : Venofer (iron sucrose injection, USP), an iron replacement product, is a brown, sterile, aq...

  • Indications
  • Venofer is indicated for the treatment of iron deficiency anemia in patients with chronic kidney disease (CKD).
  •   Read More
Venofer iron sucrose (injection) (Pronunciation: EYE urn S - Multum

Description : Venofer (iron sucrose injection, USP), an iron replacement product, is a brown, sterile, aq...

  • Indications
  • Venofer is indicated for the treatment of iron deficiency anemia in patients with chronic kidney disease (CKD).
  •   Read More
Ventavis  iloprost inhalation (Pronunciation: ill O prost - FDA

Description : Ventavis (iloprost) Inhalation Solution is a clear, colorless, sterile solution containing ...

  • Indications
  • Pulmonary Arterial Hypertension Ventavis® is indicated for the treatment of pulmonary arterial hypertension (PAH) (WHO Group 1) to improve a composite endpoint consis
  •   Read More
Ventavis iloprost inhalation (Pronunciation: ill O prost) - FDA

Description : Ventavis (iloprost) Inhalation Solution is a clear, colorless, sterile solution containing ...

  • Indications
  • Pulmonary Arterial Hypertension Ventavis® is indicated for the treatment of pulmonary arterial hypertension (PAH) (WHO Group 1) to improve a composite endpoint consis
  •   Read More
Ventavis iloprost inhalation (Pronunciation: ill O prost) - Multum

Description : Ventavis (iloprost) Inhalation Solution is a clear, colorless, sterile solution containing ...

  • Indications
  • Pulmonary Arterial Hypertension Ventavis® is indicated for the treatment of pulmonary arterial hypertension (PAH) (WHO Group 1) to improve a composite endpoint consis
  •   Read More
Ventolin Syrup  (albuterol sulfate syrup) - FDA

Description : VENTOLIN Syrup (albuterol sulfate syrup) contains albuterol sulfate, USP, the racemic form ...

  • Indications
  • VENTOLIN Syrup (albuterol sulfate syrup) is indicated for the relief of bronchospasm in adults and children 2 years of age and older with reversible obstructive airway disease
  •   Read More
Ventolin Syrup VENTOLIN Syrup (albuterol sulfate syrup) - FDA

Description : VENTOLIN Syrup (albuterol sulfate syrup) contains albuterol sulfate, USP, the racemic form ...

  • Indications
  • VENTOLIN Syrup (albuterol sulfate syrup) is indicated for the relief of bronchospasm in adults and children 2 years of age and older with reversible obstructive airway disease
  •   Read More
VePesid etoposide (oral) (Pronunciation: ee TOE poe side) - FDA

Description : VePesid® (etoposide) (also commonly known as VP-16) is a semisynthetic derivative of podoph...

  • Indications
  • VePesid (etoposide) is indicated in the management of: Small Cell Lung Cancer-VePesid (etoposide) Capsules in combination with other approved chemotherapeutic agents as first
  •   Read More
VePesid etoposide (oral) (Pronunciation: ee TOE poe side) - Multum

Description : VePesid® (etoposide) (also commonly known as VP-16) is a semisynthetic derivative of podoph...

  • Indications
  • VePesid (etoposide) is indicated in the management of: Small Cell Lung Cancer-VePesid (etoposide) Capsules in combination with other approved chemotherapeutic agents as first
  •   Read More
VePesid etoposide (oral) (Pronunciation: ee TOE poe side) - FDA

Description : VePesid® (etoposide) (also commonly known as VP-16) is a semisynthetic derivative of po...

  • Indications
  • VePesid (etoposide) is indicated in the management of: Small Cell Lung Cancer-VePesid (etoposide) Capsules in combination with other approved chemotherapeutic agents as f
  •   Read More
VePesid etoposide (oral) (Pronunciation: ee TOE poe side) - Multum

Description : VePesid® (etoposide) (also commonly known as VP-16) is a semisynthetic derivative of po...

  • Indications
  • VePesid (etoposide) is indicated in the management of: Small Cell Lung Cancer-VePesid (etoposide) Capsules in combination with other approved chemotherapeutic agents as f
  •   Read More
Veregen sinecatechins (topical) (Pronunciation: SYNE e KAT - FDA

Description : Veregen® (sinecatechins) Ointment, 15% is a botanical drug product for topical use. The dru...

  • Indications
  • Indication Veregen® is indicated for the topical treatment of external genital and perianal warts (Condylomata acuminata) in immunocompetent patients 18 years a
  •   Read More
Veregen sinecatechins (topical) (Pronunciation: SYNE e KAT - Multum

Description : Veregen® (sinecatechins) Ointment, 15% is a botanical drug product for topical use. The dru...

  • Indications
  • Indication Veregen® is indicated for the topical treatment of external genital and perianal warts (Condylomata acuminata) in immunocompetent patients 18 years a
  •   Read More
Veregen sinecatechins (topical) (Pronunciation: SYNE e KAT - FDA

Description : Veregen® (sinecatechins) Ointment, 15% is a botanical drug product for topical use. The dru...

  • Indications
  • Indication Veregen® is indicated for the topical treatment of external genital and perianal warts (Condylomata acuminata) in immunocompetent patients 18 years and old
  •   Read More
Veregen sinecatechins (topical) (Pronunciation: SYNE e KAT - Multum

Description : Veregen® (sinecatechins) Ointment, 15% is a botanical drug product for topical use. The dru...

  • Indications
  • Indication Veregen® is indicated for the topical treatment of external genital and perianal warts (Condylomata acuminata) in immunocompetent patients 18 years and old
  •   Read More
Vermox mebendazole (Pronunciation: me BEN da zole) - FDA

Description : VERMOX® (mebendazole) is a (synthetic) broad-spectrum anthelmintic available as chewable ta...

  • Indications
  • VERMOX® (mebendazole) is indicated for the treatment of Enterobius vermicularis (pinworm), Trichuris trichiura (whipworm), Ascaris lumb
  •   Read More
Vermox mebendazole (Pronunciation: me BEN da zole) - Multum

Description : VERMOX® (mebendazole) is a (synthetic) broad-spectrum anthelmintic available as chewable ta...

  • Indications
  • VERMOX® (mebendazole) is indicated for the treatment of Enterobius vermicularis (pinworm), Trichuris trichiura (whipworm), Ascaris lumb
  •   Read More
Vermox mebendazole (Pronunciation: me BEN da zole) - FDA

Description : VERMOX® (mebendazole) is a (synthetic) broad-spectrum anthelmintic available as chewable ta...

  • Indications
  • VERMOX® (mebendazole) is indicated for the treatment of Enterobius vermicularis (pinworm), Trichuris trichiura (whipworm), Ascaris lumbricoid
  •   Read More
Vermox mebendazole (Pronunciation: me BEN da zole) - Multum

Description : VERMOX® (mebendazole) is a (synthetic) broad-spectrum anthelmintic available as chewable ta...

  • Indications
  • VERMOX® (mebendazole) is indicated for the treatment of Enterobius vermicularis (pinworm), Trichuris trichiura (whipworm), Ascaris lumbricoid
  •   Read More
Versacloz (clozapine) Oral Suspension - FDA

Description : VERSACLOZ, an atypical antipsychotic drug, is a tricyclic dibenzodiazepine derivative, 8- c...

  • Indications
  • Treatment-Resistant Schizophrenia VERSACLOZ is indicated for the treatment of severely ill patients with schizophrenia who fail to respond adequately to standard antipsy
  •   Read More
Versacloz (clozapine) Oral Suspension - FDA

Description : VERSACLOZ, an atypical antipsychotic drug, is a tricyclic dibenzodiazepine derivative...

  • Indications
  • Treatment-Resistant Schizophrenia VERSACLOZ is indicated for the treatment of severely ill patients withschizophrenia who fail to respond adequately to standard ant
  •   Read More
Vesanoid tretinoin (Pronunciation: TRET i noin) - FDA

Description : VESANOID (tretinoin) is a retinoid that induces maturation of acute promyelocytic&nbs...

  • Indications
  • VESANOID (tretinoin) capsules are indicated for the induction of remission in patients with acute promyelocytic leukemia (APL), French-American-British (FAB) c
  •   Read More
Vesanoid tretinoin (Pronunciation: TRET i noin) - Multum

Description : VESANOID (tretinoin) is a retinoid that induces maturation of acute promyelocytic&nbs...

  • Indications
  • VESANOID (tretinoin) capsules are indicated for the induction of remission in patients with acute promyelocytic leukemia (APL), French-American-British (FAB) c
  •   Read More
VESIcare solifenacin (Pronunciation: sol ee FEN a sin) - FDA

Description : VESIcare® (solifenacin succinate) is a muscarinic receptor antagonist. Chemically, sol...

  • Indications
  • VESIcare is a muscarinic antagonist indicated for the treatment of overactive bladder with symptoms of urge urinary incontinence, urgency, and u
  •   Read More
VESIcare solifenacin (Pronunciation: sol ee FEN a sin) - Multum

Description : VESIcare® (solifenacin succinate) is a muscarinic receptor antagonist. Chemically, sol...

  • Indications
  • VESIcare is a muscarinic antagonist indicated for the treatment of overactive bladder with symptoms of urge urinary incontinence, urgency, and u
  •   Read More
VESIcare  solifenacin (Pronunciation: sol ee FEN a sin) - FDA

Description : VESIcare® (solifenacin succinate) is a muscarinic receptor antagonist. Chemically, solifena...

  • Indications
  • VESIcare is a muscarinic antagonist indicated for the treatment of overactive bladder with symptoms of urge urinary incontinence, urgency, and urinary frequency.
  •   Read More
VESIcare solifenacin (Pronunciation: sol ee FEN a sin) - Multum

Description : VESIcare® (solifenacin succinate) is a muscarinic receptor antagonist. Chemically, solifena...

  • Indications
  • VESIcare is a muscarinic antagonist indicated for the treatment of overactive bladder with symptoms of urge urinary incontinence, urgency, and urinary frequency.
  •   Read More
Vexol rimexolone ophthalmic (Pronunciation: rye MEX oh l - FDA

Description : VEXOL® 1% Ophthalmic Suspension is a sterile, multi-dose topical ophthalmic suspension ...

  • Indications
  • VEXOL® 1% (rimexolone ophthalmic suspension) is indicated for the treatment of postoperative inflammation following ocular surgery and in the treatment of anterior uve
  •   Read More
Vexol rimexolone ophthalmic (Pronunciation: rye MEX oh l - Multum

Description : VEXOL® 1% Ophthalmic Suspension is a sterile, multi-dose topical ophthalmic suspension ...

  • Indications
  • VEXOL® 1% (rimexolone ophthalmic suspension) is indicated for the treatment of postoperative inflammation following ocular surgery and in the treatment of anterior uve
  •   Read More
Vexol rimexolone ophthalmic (Pronunciation: rye MEX oh l - FDA

Description : VEXOL® 1% Ophthalmic Suspension is a sterile, multi-dose topical ophthalmic suspension cont...

  • Indications
  • VEXOL® 1% (rimexolone ophthalmic suspension) is indicated for the treatment of postoperative inflammation following ocular surgery and in the treatment of anterior u
  •   Read More
Vexol rimexolone ophthalmic (Pronunciation: rye MEX oh l - Multum

Description : VEXOL® 1% Ophthalmic Suspension is a sterile, multi-dose topical ophthalmic suspension cont...

  • Indications
  • VEXOL® 1% (rimexolone ophthalmic suspension) is indicated for the treatment of postoperative inflammation following ocular surgery and in the treatment of anterior u
  •   Read More
VFEND voriconazole (Pronunciation: vor i KON a zole) - FDA

Description : VFEND® (voriconazole), an azole antifungal agent is available as a lyophilized po...

  • Indications
  • VFEND is indicated for use in patients 12 years of age and older in the treatment of the following fungal infections: Invasive Aspergillosis In clinical trials, the majority
  •   Read More
VFEND voriconazole (Pronunciation: vor i KON a zole) - Multum

Description : VFEND® (voriconazole), an azole antifungal agent is available as a lyophilized po...

  • Indications
  • VFEND is indicated for use in patients 12 years of age and older in the treatment of the following fungal infections: Invasive Aspergillosis In clinical trials, the majority
  •   Read More
VFEND voriconazole (Pronunciation: vor i KON a zole) - FDA

Description : VFEND® (voriconazole), an azole antifungal agent is available as a lyophilized po...

  • Indications
  • VFEND is indicated for use in patients 12 years of age and older in the treatment of the following fungal infections: Invasive Aspergillosis In clinical trials, the majority
  •   Read More
VFEND voriconazole (Pronunciation: vor i KON a zole) - Multum

Description : VFEND® (voriconazole), an azole antifungal agent is available as a lyophilized po...

  • Indications
  • VFEND is indicated for use in patients 12 years of age and older in the treatment of the following fungal infections: Invasive Aspergillosis In clinical trials, the majority
  •   Read More
Viadur (leuprolide acetate) Implant - FDA

Description : Viadur® (leuprolide acetate implant) is a sterile nonbiodegradable, osmotically driven ...

  • Indications
  • Viadur® (leuprolide acetate implant) is indicated in the palliative treatment of advanced prostate cancer.
  •   Read More
Viadur (leuprolide acetate) Implant - FDA

Description : Viadur® (leuprolide acetate implant) is a sterile nonbiodegradable, osmotically driven mini...

  • Indications
  • Viadur® (leuprolide acetate implant) is indicated in the palliative treatment of advanced prostate cancer.
  •   Read More
Vibativ (telavancin) Lyophilized Powder for Intravenous Us - FDA

Description : VIBATIV contains telavancin hydrochloride (Figure 1), a lipoglycopeptide antibacterial that...

  • Indications
  • To reduce the development of drug-resistant bacteria and maintain the effectiveness of VIBATIV and other antibacterial drugs, VIBATIV should be used only to treat infectio
  •   Read More
Vibativ telavancin (Pronunciation: TEL a VAN sin) - FDA

Description : VIBATIV contains telavancin hydrochloride (Figure 1), a lipoglycopeptideantibacterial that...

  • Indications
  • To reduce the development of drug-resistant bacteria and maintain the effectiveness of VIBATIV and other antibacterial drugs, VIBATIV should be used only to treat in
  •   Read More
Vibativ telavancin (Pronunciation: TEL a VAN sin) - Multum

Description : VIBATIV contains telavancin hydrochloride (Figure 1), a lipoglycopeptideantibacterial that...

  • Indications
  • To reduce the development of drug-resistant bacteria and maintain the effectiveness of VIBATIV and other antibacterial drugs, VIBATIV should be used only to treat in
  •   Read More
Viberzi (eluxadoline) - FDA

Description : The active ingredient in VIBERZI is eluxadoline, a mu-opioid receptor agonist. The f...

  • Indications
  • VIBERZI is indicated in adults for the treatment of irritable bowel syndromewith diarrhea (IBSD).
  •   Read More
Vibramycin Intravenous doxycycline hyclate) for Injection - FDA

Description : Vibramycin (doxycycline hyclate for injection) Intravenous is a broad-spectrum antibiotic s...

  • Indications
  • Doxycycline is indicated in infections caused by the following microorganisms: Rickettsiae (Rocky Mountain spotted fever, typhus fever, and the typhus group, Q fever, ric
  •   Read More
Vibramycin Intravenous doxycycline hyclate for Intravenous injection - FDA

Description : Vibramycin (doxycycline hyclate for injection) Intravenous is an antibacterial drug synthetical...

  • Indications
  • To reduce the development of drug-resistant bacteria and maintain effectiveness of Vibramycin and other antibacterial drugs, Vibramycin should be used only to treat
  •   Read More
Victoza liraglutide (Pronunciation: LIR a GLOO tde) - FDA

Description : Victoza® contains liraglutide, an analog of human GLP-1 and acts as a GLP-1 receptor ag...

  • Indications
  • Victoza® is indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus. Important Limitations of Use Because
  •   Read More
Victoza liraglutide (Pronunciation: LIR a GLOO tde) - Multum

Description : Victoza® contains liraglutide, an analog of human GLP-1 and acts as a GLP-1 receptor ag...

  • Indications
  • Victoza® is indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus. Important Limitations of Use Because
  •   Read More
Victoza liraglutide (Pronunciation: LIR a GLOO tde) - FDA

Description : Victoza contains liraglutide, an analog of human GLP-1 and acts as a GLP-1 receptor a...

  • Indications
  • Victoza is indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus. Important Limitations Of Use Because of t
  •   Read More
Victoza liraglutide (Pronunciation: LIR a GLOO tde) - Multum

Description : Victoza contains liraglutide, an analog of human GLP-1 and acts as a GLP-1 receptor a...

  • Indications
  • Victoza is indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus. Important Limitations Of Use Because of t
  •   Read More
Victrelis boceprevir (Pronunciation: boe SEP re vir) - FDA

Description : VICTRELIS (boceprevir) is an inhibitor of the hepatitis C virus (HCV) non-structural protei...

  • Indications
  • VICTRELIS® (boceprevir) is indicated for the treatment of chronic hepatitis C genotype 1 infection, in combination with peginterferon alfa and ribavirin, in adult pati
  •   Read More
Victrelis boceprevir (Pronunciation: boe SEP re vir) - Multum

Description : VICTRELIS (boceprevir) is an inhibitor of the hepatitis C virus (HCV) non-structural protei...

  • Indications
  • VICTRELIS® (boceprevir) is indicated for the treatment of chronic hepatitis C genotype 1 infection, in combination with peginterferon alfa and ribavirin, in adult pati
  •   Read More
Victrelis boceprevir (Pronunciation: boe SEP re vir) - FDA

Description : VICTRELIS (boceprevir) is an inhibitor of the hepatitis C virus (HCV) non-structural protein 3 ...

  • Indications
  • VICTRELIS® (boceprevir) is indicated for the treatment of chronic hepatitis Cgenotype 1 infection, in combination with peginterferon alfa and ribavirin, in adult
  •   Read More
Victrelis boceprevir (Pronunciation: boe SEP re vir) - Multum

Description : VICTRELIS (boceprevir) is an inhibitor of the hepatitis C virus (HCV) non-structural protein 3 ...

  • Indications
  • VICTRELIS® (boceprevir) is indicated for the treatment of chronic hepatitis Cgenotype 1 infection, in combination with peginterferon alfa and ribavirin, in adult
  •   Read More
Vidaza azacitidine (Pronunciation: ay za SYE ti deen) - FDA

Description : VIDAZA (azacitidine for injection) contains azacitidine, which is a pyrimidine nucleoside a...

  • Indications
  • Myelodysplastic Syndromes (MDS) VIDAZA® is indicated for treatment of patients with the following French-American-British (FAB) myelodysplastic syndrome subtypes: re
  •   Read More
Vidaza azacitidine (Pronunciation: ay za SYE ti deen) - Multum

Description : VIDAZA (azacitidine for injection) contains azacitidine, which is a pyrimidine nucleoside analo...

  • Indications
  • Myelodysplastic Syndromes (MDS) VIDAZA® is indicated for treatment of patients with the following French-American-British (FAB) myelodysplastic syndrome subtypes: re
  •   Read More
Vidaza azacitidine (Pronunciation: ay za SYE ti deen) - FDA

Description : VIDAZA (azacitidine for injection) contains azacitidine, which is a pyrimidinenucleoside&n...

  • Indications
  • Myelodysplastic Syndromes (MDS) VIDAZA® is indicated for treatment of patients with the following French-American-British (FAB) myelodysplastic syndrome subtype
  •   Read More
Vidaza azacitidine (Pronunciation: ay za SYE ti deen) - Multum

Description : VIDAZA (azacitidine for injection) contains azacitidine, which is a pyrimidinenucleoside&n...

  • Indications
  • Myelodysplastic Syndromes (MDS) VIDAZA® is indicated for treatment of patients with the following French-American-British (FAB) myelodysplastic syndrome subtype
  •   Read More
Videx, Videx EC didanosine (Pronunciation: dye DAN oh seen) - Multum

Description : VIDEX® EC is the brand name for an enteric-coated formulation of didanosine, USP, a syn...

  • Indications
  • VIDEX® EC (didanosine, USP), also known as ddI, in combination with other antiretroviral agents is indicated for the treatment of human immunodeficiency virus (HIV)-1 infe
  •   Read More
Videx, Videx EC didanosine (Pronunciation: dye DAN oh seen) - Multum

Description : VIDEX® EC is the brand name for an enteric-coated formulation of didanosine, USP, a syn...

  • Indications
  • VIDEX® EC (didanosine, USP), also known as ddI, in combination with other antiretroviral agents is indicated for the treatment of human immunodeficiency virus (HIV)-1 infe
  •   Read More
Videx, Videx EC didanosine (Pronunciation: dye DAN oh seen) - Multum

Description : VIDEX® EC is the brand name for an enteric-coated formulation of didanosine, USP, a syn...

  • Indications
  • VIDEX® EC (didanosine, USP), also known as ddI, in combination with other antiretroviral agents is indicated for the treatment of human immunodeficiency virus (HIV)-1 infe
  •   Read More
Videx, Videx EC didanosine (Pronunciation: dye DAN oh seen) - Multum

Description : VIDEX® EC is the brand name for an enteric-coated formulation of didanosine, USP, a syn...

  • Indications
  • VIDEX® EC (didanosine, USP), also known as ddI, in combination with other antiretroviral agents is indicated for the treatment of human immunodeficiency virus (HIV)-1 infe
  •   Read More
Videx, Videx EC  didanosine (Pronunciation: dye DAN oh seen) - Multum

Description : VIDEX® is a brand name for didanosine, USP, a synthetic purine nucleoside analogue acti...

  • Indications
  • VIDEX® (didanosine, USP), also known as ddI, in combination with other antiretroviral agents is indicated for the treatment of human immunodeficiency virus (HIV)-1 infecti
  •   Read More
Videx, Videx EC didanosine (Pronunciation: dye DAN oh seen) - FDA

Description : VIDEX® is a brand name for didanosine, USP, a synthetic purine nucleoside analogue active a...

  • Indications
  • VIDEX® (didanosine, USP), also known as ddI, in combination with otherantiretroviral agents is indicated for the treatment of human immunodeficiency virus (HIV)
  •   Read More
Videx, Videx EC didanosine (Pronunciation: dye DAN oh seen) - Multum

Description : VIDEX® is a brand name for didanosine, USP, a synthetic purine nucleoside analogue active a...

  • Indications
  • VIDEX® (didanosine, USP), also known as ddI, in combination with otherantiretroviral agents is indicated for the treatment of human immunodeficiency virus (HIV)-1 inf
  •   Read More
Videx, Videx EC didanosine (Pronunciation: dye DAN oh seen) - FDA

Description : VIDEX® EC is the brand name for an enteric-coated formulation of didanosine, USP,...

  • Indications
  • VIDEX® EC (didanosine, USP), also known as ddI, in combination with otherantiretroviral agents is indicated for the treatment of humanimmunodeficiency viru
  •   Read More
Videx, Videx EC didanosine (Pronunciation: dye DAN oh seen) - Multum

Description : VIDEX® EC is the brand name for an enteric-coated formulation of didanosine, USP,...

  • Indications
  • VIDEX® EC (didanosine, USP), also known as ddI, in combination with otherantiretroviral agents is indicated for the treatment of humanimmunodeficiency viru
  •   Read More
Viekira Pak ombitasvir, paritaprevir, and ritonavir tablets; d - FDA

Description : VIEKIRA PAK is ombitasvir, paritaprevir, ritonavir fixed dose combination tablets copackage...

  • Indications
  • VIEKIRA PAK with or without ribavirin is indicated for the treatment of patients with genotype 1 chronic hepatitis C virus (HCV) infection including those with compensated
  •   Read More
Viekira Pak (ombitasvir, paritaprevir, and ritonavir tablets; - FDA

Description : VIEKIRA PAK (ombitasvir, paritaprevir, and ritonavir tablets; dasabuvir) Tablets DESCRIPT...

  • Indications
  • VIEKIRA PAK with or without ribavirin is indicated for the treatment of patients with genotype 1 chronic hepatitis C virus (HCV) infection including those
  •   Read More
Vigamox moxifloxacin ophthalmic (Pronunciation: MOX i FLOX - FDA

Description : VIGAMOX® (moxifloxacin hydrochloride ophthalmic solution) 0.5% is a sterile solution for to...

  • Indications
  • VIGAMOX® solution is indicated for the treatment of bacterial conjunctivitis caused by susceptible strains of the following organisms: Corynebacterium species*Micrococcus
  •   Read More
Vigamox moxifloxacin ophthalmic (Pronunciation: MOX i FLOX - Multum

Description : VIGAMOX® (moxifloxacin hydrochloride ophthalmic solution) 0.5% is a sterile solution ...

  • Indications
  • VIGAMOX® solution is indicated for the treatment of bacterial conjunctivitis caused by susceptible strains of the following organisms: Corynebacterium species*Micrococcus
  •   Read More
Vigamox moxifloxacin ophthalmic (Pronunciation: MOX i FLOX - FDA

Description : VIGAMOX® (moxifloxacin hydrochloride ophthalmic solution) 0.5% is a sterile solution for to...

  • Indications
  • VIGAMOX® solution is indicated for the treatment of bacterial conjunctivitis caused by susceptible strains of the following organisms: Corynebacterium species*Micrococcus
  •   Read More
Vigamox moxifloxacin ophthalmic (Pronunciation: MOX i FLOX - Multum

Description : VIGAMOX® (moxifloxacin hydrochloride ophthalmic solution) 0.5% is a sterile solution for to...

  • Indications
  • VIGAMOX® solution is indicated for the treatment of bacterial conjunctivitis caused by susceptible strains of the following organisms: Corynebacterium species*Micrococcus
  •   Read More
VIGIV Vaccinia Immune Globulin Intravenous (Human) - FDA

Description : CNJ-016, Vaccinia Immune Globulin Intravenous (Human) (VIGIV (vaccinia immune globulin intr...

  • Indications
  • Vaccinia Immune Globulin Intravenous (Human) (VIGIV (vaccinia immune globulin intravenous) ) is indicated for the treatment and/or modification of the following conditions
  •   Read More
VIGIV Vaccinia Immune Globulin Intravenous (Human) - FDA

Description : CNJ-016, Vaccinia Immune Globulin Intravenous (Human) (VIGIV (vaccinia immune globulin intraven...

  • Indications
  • Vaccinia Immune Globulin Intravenous (Human) (VIGIV (vaccinia immune globulin intravenous) ) is indicated for the treatment and/or modification of the following conditions:
  •   Read More
Viibryd vilazodone (Pronunciation: vil AZ oh done) - FDA

Description : VIIBRYD Tablets for oral administration contain polymorph Form IV vilazodone hydrochloride (HCl...

  • Indications
  • VIIBRYD® is indicated for the treatment of major depressive disorder (MDD). The efficacy of VIIBRYD was established in two 8-week, randomized, double-blind, placebo-contro
  •   Read More
Viibryd vilazodone (Pronunciation: vil AZ oh done) - Multum

Description : VIIBRYD Tablets for oral administration contain polymorph Form IV vilazodone hydrochloride (HCl...

  • Indications
  • VIIBRYD® is indicated for the treatment of major depressive disorder (MDD). The efficacy of VIIBRYD was established in two 8-week, randomized, double-blind, placebo-contro
  •   Read More
Viibryd vilazodone (Pronunciation: vil AZ oh done) - FDA

Description : VIIBRYD Tablets for oral administration contain polymorph Form IV vilazodone hydrochloride (HCl...

  • Indications
  • VIIBRYD® is indicated for the treatment of major depressive disorder (MDD). The efficacy of VIIBRYD was established in two 8-week, randomized, double-blind, placebo-contro
  •   Read More
Viibryd vilazodone (Pronunciation: vil AZ oh done) - Multum

Description : VIIBRYD Tablets for oral administration contain polymorph Form IV vilazodone hydrochloride (HCl...

  • Indications
  • VIIBRYD® is indicated for the treatment of major depressive disorder (MDD). The efficacy of VIIBRYD was established in two 8-week, randomized, double-blind, placebo-contro
  •   Read More
Vimizim (elosulfase alfa) Injection, for Intravenous Use - FDA

Description : Vimizim is a formulation of elosulfase alfa, which is a purified human enzyme produced by...

  • Indications
  • Vimizim (elosulfase alfa) is indicated for patients with Mucopolysaccharidosis type IVA (MPS IVA; Morquio A syndrome).
  •   Read More
Vimizim (elosulfase alfa) Injection, for Intravenous Use - FDA

Description : Vimizim is a formulation of elosulfase alfa, which is a purified human enzyme produced by ...

  • Indications
  • Vimizim (elosulfase alfa) is indicated for patients with Mucopolysaccharidosis type IVA (MPS IVA; Morquio A syndrome).
  •   Read More
Vimovo esomeprazole and naproxen (Pronunciation: ee soe M - FDA

Description : The active ingredients of VIMOVO are naproxen which is a NSAID and esomeprazole magnesium ...

  • Indications
  • VIMOVO is a combination product that contains naproxen and esomeprazole. It is indicated for the relief of signs and symptoms of osteoarthritis, rheumatoid arthritis and a
  •   Read More
Vimovo esomeprazole and naproxen (Pronunciation: ee soe M - Multum

Description : The active ingredients of VIMOVO are naproxen which is a NSAID and esomeprazole magnesium ...

  • Indications
  • VIMOVO is a combination product that contains naproxen and esomeprazole. It is indicated for the relief of signs and symptoms of osteoarthritis, rheumatoid arthritis and a
  •   Read More
Vimovo esomeprazole and naproxen (Pronunciation: ee soe M - FDA

Description : The active ingredients of VIMOVO are naproxen which is a NSAID and esomeprazole magne...

  • Indications
  • VIMOVO is a combination product that contains naproxen and esomeprazole. It is indicated for the relief of signs and symptoms of osteoarthritis,rheumatoid arthritis 
  •   Read More
Vimovo esomeprazole and naproxen (Pronunciation: ee soe M - Multum

Description : The active ingredients of VIMOVO are naproxen which is a NSAID and esomeprazole magne...

  • Indications
  • VIMOVO is a combination product that contains naproxen and esomeprazole. It is indicated for the relief of signs and symptoms of osteoarthritis,rheumatoid arthritis 
  •   Read More
Vimpat lacosamide (Pronunciation: la KOE sa mide) - FDA

Description : The chemical name of lacosamide, the single (R)-enantiomer, is (R)-2-acetamido-N-benzyl-3me...

  • Indications
  • VIMPAT (lacosamide) is indicated in patients 17 years and older with partial-onset seizures as monotherapy or adjunctive therapy. VIMPAT (lacosamide) injection for intrav
  •   Read More
Vimpat lacosamide (Pronunciation: la KOE sa mide) - Multum

Description : The chemical name of lacosamide, the single (R)-enantiomer, is (R)-2-acetamido-N-benzyl-3me...

  • Indications
  • VIMPAT (lacosamide) is indicated in patients 17 years and older with partial-onset seizures as monotherapy or adjunctive therapy. VIMPAT (lacosamide) injection for intrav
  •   Read More
Vimpat lacosamide (Pronunciation: la KOE sa mide) - FDA

Description : The chemical name of lacosamide, the single (R)-enantiomer, is (R)-2-acetamido-N-benzyl-3methox...

  • Indications
  • VIMPAT (lacosamide) is indicated in patients 17 years and older with partial-onset seizures as monotherapy or adjunctive therapy. VIMPAT (lacosamide) injection for intravenou
  •   Read More
Vimpat lacosamide (Pronunciation: la KOE sa mide) - Multum

Description : The chemical name of lacosamide, the single (R)-enantiomer, is (R)-2-acetamido-N-benzyl-3methox...

  • Indications
  • VIMPAT (lacosamide) is indicated in patients 17 years and older with partial-onset seizures as monotherapy or adjunctive therapy. VIMPAT (lacosamide) injection for intravenou
  •   Read More
Vinblastine Sulfate VinBLAStine Sulfate for Injection USP (vinblastine - FDA

Description : Vinblastine Sulfate for Injection USP is vincaleukoblastine, sulfate (1:1) (salt). It is the sa...

  • Indications
  • Vinblastine sulfate (vinblastine sulfate injection) is indicated in the palliative treatment of the following: Frequently Responsive Malignancies Generalized Hodgk
  •   Read More
Vinblastine Sulfate VinBLAStine Sulfate for Injection USP (vinblastine - FDA

Description : Vinblastine Sulfate for Injection USP is vincaleukoblastine, sulfate (1:1) (salt). It is the sa...

  • Indications
  • Vinblastine sulfate (vinblastine sulfate injection) is indicated in the palliative treatment of the following: Frequently Responsive Malignancies Generalized Hodgk
  •   Read More
Vincristine Sulfate Injection Vincristine Sulfate Injection, USP (vincristine su - FDA

Description : Vincristine Sulfate Injection, USP (vincristine sulfate) is the salt of an alkaloid obtained fr...

  • Indications
  • Vincristine sulfate injection (vincristine sulfate) is indicated in acute leukemia. Vincristine sulfate injection (vincristine sulfate) has also been shown to be useful
  •   Read More
Vincristine Sulfate Injection Vincristine Sulfate Injection, USP (vincristine su - FDA

Description : Vincristine Sulfate Injection, USP (vincristine sulfate) is the salt of an alkaloid obtained fr...

  • Indications
  • Vincristine sulfate injection (vincristine sulfate) is indicated in acute leukemia. Vincristine sulfate injection (vincristine sulfate) has also been shown to be useful
  •   Read More
Vincristine Sulfate Injection Vincristine Sulfate Injection, USP (vincristine su - FDA

Description : Vincristine Sulfate Injection, USP (vincristine sulfate) is the salt of an alkaloid obtained fr...

  • Indications
  • Vincristine sulfate injection (vincristine sulfate) is indicated in acute leukemia. Vincristine sulfate injection (vincristine sulfate) has also been shown to be useful
  •   Read More
Viorele desogestrel and ethinyl estradiol - FDA

Description : VIORELE (desogestrel and ethinyl estradiol tablets USP and ethinyl estradiol tablets USP) p...

  • Indications
  • VIORELE (desogestrel and ethinyl estradiol tablets USP and ethinyl estradiol tablets USP) is indicated for the prevention of pregnancy in women who elect to use this produ
  •   Read More
Viorele (desogestrel and ethinyl estradiol) Tablets USP, 0 - FDA

Description : VIORELE (desogestrel and ethinyl estradiol tablets USP and ethinyl estradiol tablets USP) provi...

  • Indications
  • VIORELE (desogestrel and ethinyl estradiol tablets USP and ethinyl estradiol tablets USP) is indicated for the prevention of pregnancy in women who elect to use this
  •   Read More
Vioxx (rofecoxib) Tablets - FDA

Description : VIOXX* (rofecoxib) is described chemically as 4-[4-(methylsulfonyl)phenyl]-3-phenyl-2(5H)-f...

  • Indications
  • VIOXX (rofecoxib) is indicated: For relief of the signs and symptoms of osteoarthritis. For relief of the signs and symptoms of rheumatoid arthritis in adults. For reli
  •   Read More
Vioxx (rofecoxib) for Oral Suspension - FDA

Description : VIOXX* (rofecoxib) is described chemically as 4-[4-(methylsulfonyl)phenyl]-3-phenyl-2(5H)-...

  • Indications
  • VIOXX (rofecoxib) is indicated: For relief of the signs and symptoms of osteoarthritis. For relief of the signs and symptoms of rheumatoid arthritis in adults
  •   Read More
Vira-A (vidarabine monohydrate) Ointment - FDA

Description : VIRA-A is the trade name for vidarabine (also known as adenine arabinoside and Ara-A), an antiv...

  • Indications
  • VIRA-A (vidarabine) Ophthalmic Ointment, 3%, is indicated for the treatment of acute keratoconjunctivitis and recurrent epithelial keratitis 
  •   Read More
Vira-A (vidarabine monohydrate) Ointment - FDA

Description : VIRA-A is the trade name for vidarabine (also known as adenine arabinoside and Ara-A), an antiv...

  • Indications
  • VIRA-A (vidarabine) Ophthalmic Ointment, 3%, is indicated for the treatment of acute keratoconjunctivitis and recurrent epithelial keratitis 
  •   Read More
Viracept nelfinavir (Pronunciation: nel FIN a veer) - FDA

Description : VIRACEPT® (nelfinavir mesylate) is an inhibitor of the human immunodeficiency virus typ...

  • Indications
  • VIRACEPT in combination with other antiretroviral agents is indicated for the treatment of HIV-1 infection.
  •   Read More
Viracept nelfinavir (Pronunciation: nel FIN a veer) - Multum

Description : VIRACEPT® (nelfinavir mesylate) is an inhibitor of the human immunodeficiency virus typ...

  • Indications
  • VIRACEPT in combination with other antiretroviral agents is indicated for the treatment of HIV-1 infection.
  •   Read More
Viracept nelfinavir (Pronunciation: nel FIN a veer) - FDA

Description : VIRACEPT® (nelfinavir mesylate) is an inhibitor of the human immunodeficiency virus&nb...

  • Indications
  • VIRACEPT in combination with other antiretroviral agents is indicated for the treatment of HIV-1 infection.
  •   Read More
Viracept nelfinavir (Pronunciation: nel FIN a veer) - Multum

Description : VIRACEPT® (nelfinavir mesylate) is an inhibitor of the human immunodeficiency virus&nb...

  • Indications
  • VIRACEPT in combination with other antiretroviral agents is indicated for the treatment of HIV-1 infection.
  •   Read More
Viramune, Viramune XR nevirapine (Pronunciation: ne VYE ra peen) - FDA

Description : VIRAMUNE is the brand name for nevirapine, a non-nucleoside reverse transcriptase inhibitor...

  • Indications
  • VIRAMUNE is indicated for combination antiretroviral treatment of HIV-1 infection in adults and in pediatric patients 15 days and older [see Clinical Studies]. Additional
  •   Read More
Viramune, Viramune XR nevirapine (Pronunciation: ne VYE ra peen) - Multum

Description : VIRAMUNE is the brand name for nevirapine, a non-nucleoside reverse transcriptase inhibitor...

  • Indications
  • VIRAMUNE is indicated for combination antiretroviral treatment of HIV-1 infection in adults and in pediatric patients 15 days and older [see Clinical Studies]. Additional
  •   Read More
Viramune, Viramune XR nevirapine (Pronunciation: ne VYE ra peen) - FDA

Description : VIRAMUNE XR is the brand name for nevirapine extended-release tablets. Nevirapine is a non-...

  • Indications
  • VIRAMUNE XR is indicated for use in combination with other antiretroviral agents for the treatment of HIV-1 infection in adults and in children 6 to less than 18 years of
  •   Read More
Viramune, Viramune XR nevirapine (Pronunciation: ne VYE ra peen) - Multum

Description : VIRAMUNE XR is the brand name for nevirapine extended-release tablets. Nevirapine is a non-...

  • Indications
  • VIRAMUNE XR is indicated for use in combination with other antiretroviral agents for the treatment of HIV-1 infection in adults and in children 6 to less than 18 years of
  •   Read More
Viramune, Viramune XR nevirapine (Pronunciation: ne VYE ra peen) - FDA

Description : VIRAMUNE is the brand name for nevirapine, a non-nucleoside reverse transcriptase inhibitor (NN...

  • Indications
  • VIRAMUNE is indicated for combination antiretroviral treatment of HIV-1 infection in adults and in pediatric patients 15 days and older [see Clinical Studi
  •   Read More
Viramune, Viramune XR nevirapine (Pronunciation: ne VYE ra peen) - Multum

Description : VIRAMUNE is the brand name for nevirapine, a non-nucleoside reverse transcriptase inhibitor (NN...

  • Indications
  • VIRAMUNE is indicated for combination antiretroviral treatment of HIV-1 infection in adults and in pediatric patients 15 days and older [see Clinical Studi
  •   Read More
Viramune, Viramune XR nevirapine (Pronunciation: ne VYE ra peen) - FDA

Description : VIRAMUNE XR is the brand name for nevirapine extended-release tablets. Nevirapine is a non-nucl...

  • Indications
  • VIRAMUNE XR is indicated for use in combination with other antiretroviralagents for the treatment of HIV-1 infection in adults and in children 6 to less than 18 year
  •   Read More
Viramune, Viramune XR nevirapine (Pronunciation: ne VYE ra peen) - Multum

Description : VIRAMUNE XR is the brand name for nevirapine extended-release tablets. Nevirapine is a non-nucl...

  • Indications
  • VIRAMUNE XR is indicated for use in combination with other antiretroviralagents for the treatment of HIV-1 infection in adults and in children 6 to less than 18 year
  •   Read More
Virazole (ribavirin) for Inhalation Solution, USP - FDA

Description : VIRAZOLE is a brand name for ribavirin, a synthetic nucleoside with antiviral activity. VIR...

  • Indications
  • VIRAZOLE (ribavirin) is indicated for the treatment of hospitalized infants and young children with severe lower respiratory tract infections due to respiratory syncytial
  •   Read More
Virazole (ribavirin) for Inhalation Solution, USP - FDA

Description : VIRAZOLE is a brand name for ribavirin, a synthetic nucleoside with antiviral activity. VIRAZOL...

  • Indications
  • VIRAZOLE (ribavirin) is indicated for the treatment of hospitalized infants and young children with severe lower respiratory tract infections due torespiratory syncy
  •   Read More
Viread tenofovir (Pronunciation: ten OF oh vir) - FDA

Description : VIREAD is the brand name for tenofovir disoproxil fumarate (a prodrug of tenofovir) w...

  • Indications
  • HIV-1 Infection VIREAD® is indicated in combination with other antiretroviral agents for the treatment of HIV-1 infection in adults and pediatric patients
  •   Read More
Viread tenofovir (Pronunciation: ten OF oh vir) - Multum

Description : VIREAD is the brand name for tenofovir disoproxil fumarate (a prodrug of tenofovir) w...

  • Indications
  • HIV-1 Infection VIREAD® is indicated in combination with other antiretroviral agents for the treatment of HIV-1 infection in adults and pediatric patients
  •   Read More
VisionBlue (trypan blue) Ophthalmic Solution - FDA

Description : VisionBlue® (trypan blue ophthalmic solution) 0.06% is a sterile solution of trypan blue (a...

  • Indications
  • VisionBlue® (trypan blue) is indicated for use as an aid in ophthalmic surgery by staining the anterior capsule of the lens.
  •   Read More
Rx Scoops
Featured Topics
Advertisements
Copyrights ©2014: Rx Scoops - Designed & Developed By - GOIGI